Kimmtrak(tebentafusp-tebn)

KIMMTRAK is a bispecific gp100 peptide-HLA-directed CD3 T cell engager recommended for adult patients with metastatic or incurable uveal melanoma who test positive for HLA-A*02:01.

Recommended Dosage:

The recommended dosing schedule involves administering 20 mcg intravenously on the first day, 30 mcg on the eighth day, 68 mcg on the fifteenth day, and then 68 mcg weekly thereafter. Dilute the medication and administer it via intravenous infusion lasting 15-20 minutes.

• Skin reactions such as rash, itching, and swelling of the skin have been observed in patients receiving KIMMTRAK. Should these reactions arise, their management should be based on the persistence and severity of the symptoms.
• Increases in liver enzymes have been noted in patients undergoing KIMMTRAK treatment. Monitoring of ALT, AST, and total bilirubin levels is recommended.
• Regarding embryo-fetal toxicity, there is a potential risk of harm to the fetus. Patients should be informed about this risk, particularly those of reproductive potential, and advised to use effective contraception methods.

If you are considering the import of Kimmtrak (tebentafusp-tebn) to India, please be aware that Kimmtrak can be imported by patients or government hospitals solely in the name of the patients. The following documentation is essential for the successful import of this medication:

Required Documentation for Import:

• A valid prescription from a qualified medical practitioner.
• Diagnostic reports of the patient.
• Government-issued identification proof for the patient, as recognized by the Government of India.

Order Confirmation Process: 

The order for Kimmtrak will be confirmed upon the receipt of the following documents:

• A valid prescription from a qualified doctor.
• An import permit, if applicable.

Availability of Kimmtrak in India: 

Kimmtrak (tebentafusp-tebn) is classified as a prescription pharmaceutical drug. Consequently, it legally requires a medical prescription to be dispensed. Indian Pharma Network (IPN) specializes in facilitating the import of cancer medicines through named patient supply (NPS), ensuring transparency and authenticity by sourcing from reputable suppliers in the USA, Canada, Europe, and Australia.

Kimmtrak (tebentafusp-tebn) can be made accessible to patients, doctors, and hospitals in various cities across India, including but not limited to Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, and Pune. To confirm an order, a valid prescription from a doctor and an import permit will be required.

IPN (Indian Pharma Network) is dedicated to facilitating the supply of Elahere (prescription medicines) to locations both within India and worldwide, while adhering to relevant legal requirements.

Our commitment lies in assuring quality and timely delivery to meet the healthcare needs of patients and medical professionals across the globe.

Indian Pharma Network is proficient in sourcing Kimmtrak (tebentafusp-tebn) from around the world and ensuring efficient delivery to patients. We provide worldwide access to the best available treatments and expedite prescription dispensing and delivery, with all prescriptions being dispensed and scrutinized by registered pharmacists before dispatching them to the patient’s address, exclusively from New Delhi, India.

 What is KIMMTRAK used for?

KIMMTRAK, or Tebentafusp-tebn, is recommended for adult patients diagnosed with metastatic or unresectable uveal melanoma who test positive for HLA-A*02:01. It’s a bispecific gp100 peptide-HLA-directed CD3 T cell engager.

What’s the recommended dosage and administration of KIMMTRAK?

The suggested dosing involves administering 20 mcg intravenously on the first day, 30 mcg on the eighth day, 68 mcg on the fifteenth day, and then 68 mcg weekly thereafter. Dilute the medication and administer it via a 15-20 minute intravenous infusion.

What precautions should one take while using KIMMTRAK?

Patients using KIMMTRAK might experience skin reactions like rash, itching, and skin swelling. Management of these reactions should align with the persistence and severity of symptoms. Monitoring of liver enzymes (ALT, AST, bilirubin) is also recommended. Additionally, there’s a potential risk of harm to the fetus, so patients of reproductive potential should use effective contraception methods.

Is KIMMTRAK readily available in India?

KIMMTRAK falls under prescription pharmaceuticals and requires a doctor’s prescription for dispensing. Indian Pharma Network (IPN) specializes in importing cancer medicines via named patient supply (NPS) from trusted suppliers globally. The drug is accessible in various Indian cities. To initiate an order, a valid prescription and import permit are required. For inquiries and ordering, contact details are provided: Phone: +91-9310090915, Toll-Free: 1800-889-1064, Email: info@indianpharmanetwork.in. IPN ensures quality and timely delivery adhering to legal requirements.